DOCTOR INTERVIEWS
Endocrine

39: What is Graves’ Disease? What is Hyperthyroidism? with Doctor David Schneider from University of Wisconsin
Dr. Schneider specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands.
This episode explores the following topics:
Treatment options for Graves disease.
Treatment options for hyperthyroidism.
Dangers of hyperthyroidism medication.
Symptoms of hyperthyroidism.
Why smokers are a higher risk in the treatment of hyperthyroidism.

37: Thyroid Cancer Is Not Going to Kill You (Papillary), with Dr. Amanda Laird from Rutgers Cancer Institute of NJ
Dr. Amanda Laird, MD is an endocrine surgeon and Chief of Endocrine Surgery at the Rutgers Cancer Institute of New Jersey in New Brunswick, New

33: Combination Therapy of T4 and T3: Combat Hypothyroidism, Weight Gain, and Fatigue with Dr. Antonio Bianco from Rush University
Thyroidectomy often leads to hypothyroidism-like symptoms. This includes brain fog, sluggishness, weight gain, unmotivated, and water accumulation.
Dr. Bianco’s research has revealed the connection between thyroidectomy, hypothyroidism symptoms, and T4 only therapy. Although T4 only therapy works for the majority, others report serious symptoms. Listen to this segment to hear greater detail.

31: [Spanish] La Conexión Entre el Corazón y el Hipotiroidismo. Entrevista con la Dra. Gabriela Brenta de Buenos Aires
En esta entrevista, discutimos los siguientes temas:
* Menos función cardiovascular
* Hipertensión
* La conexión entre el funcionamiento del corazón menos y el hipotiroidismo
* El riesgo cardiovascular
* Resistencia cardiovascular
* Mayor colesterol LDL e hipotiroidismo
* Hipotiroidismo subclínico y riesgo
* Niveles de TSH
* Niveles de TSH por encima de 10
* Colesterol e hipotiroidismo
* Riesgo residual y estatinas
* Mejorando la absorción de T4
* Levotiroxina y buen cumplimiento
* Osteoporosis

21: No Biopsia es 100% Exacta⎥Exámenes Moleculares son los Mejores, con Dr. Paul Y. Casanova
Dr. Paul Y. Casanova-Romero, M.D., M.P.H., F.A.C.P., F.A.C.E, E.C.N.U, que se unió a Palm Beach Diabetes y Endocrine Specialists en 2012, recibió su grado médico con honores (Summa Cum Laude) y Doctor en Ciencias Médicas (DMSc), de la Universidad de Zulia, la Escuela de Medicina en Venezuela.
* ¿Cómo se identifican los nódulos y por qué ocurren? autoexamen o en la oficina del médico
* La mayoría de los nódulos son benignos pero ocurren porque en mas de 70% de la población
* ¿Qué tests puede realizar un médico para evaluar el nódulo?
* Ninguna test es 100%
* Ultrasonido – qué están buscando en general
* Que es ojo fina y el proceso general
* Tests moleculares
* ¿Qué tipos de resultados se pueden obtener de la citología y qué significan?
* La mayoria de ojo finas son benigno

18: Managing Indeterminate Thyroid Nodules, with Dr. Kimberly Vanderveen from Denver Center for Endocrine Surgery
Kimberly Vanderveen, MD is a Colorado native and graduate of Bear Creek High School in Lakewood, CO. She received her bachelor’s degree with honors from Muhlenberg College in Allentown, PA. She then earned her medical degree from Northwestern University in Chicago, IL in 2001.
In this episode, the following topics are discussed:
* Two roads of tests: rule out and malignant markers
* Rule-out tests picks up innocent behavior pattern. Most common is Afirma
* Malignant markers, or rule-in tests, are useful at determining extent of surgery, and help avoid a second or third surgery. ThyroSeq, ThyraMIR, Rosetta
* Do patients get both tests? Rule out and behavior?
* Approximately 15% of FNA’s come back indeterminate. Some centers as high as 30%
* Managing indeterminate nodules when a patient chooses no surgery.
* Taking into account emotional, financial, and lifestyle goals of the patient.